Moderation of calpain activity promotes neovascular integration and lumen formation during VEGF-induced pathological angiogenesis

PLoS ONE

Volumn 5, Issue 10, 2010, Pages

  Hoang, Mien V ^a   Nagy, Janice A ^a   Fox, Joan E B ^b   Senger, Donald R ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALPAIN; CALPAIN 1; CALPAIN INHIBITOR 1; CYSTEINE PROTEINASE INHIBITOR; PACLITAXEL; TAU PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN A;

ACTIN FILAMENT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOSKELETON; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; ENZYME REGULATION; FEMALE; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MICROTUBULE; MICROVASCULATURE; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PERFUSION; SKIN BLOOD VESSEL; WILD TYPE; ANIMAL; CELL LINE; DOMINANT GENE; GENETICS; METABOLISM; MORPHOGENESIS; MUTATION; PHYSIOLOGY; SKIN; VASCULARIZATION;

ANIMALS; CALPAIN; CELL LINE; GENES, DOMINANT; MICE; MORPHOGENESIS; MUTATION; NEOVASCULARIZATION, PATHOLOGIC; SKIN; TRANSDUCTION, GENETIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 78149450610     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0013612     Document Type: Article

References (66)

1. Ferrara N, Gerber HP, LeCouter J (2003) The biology of VEGF and its receptors. Nat Med 9: 669-676.
2. Jain RK (2003) Molecular regulation of vessel maturation. Nat Med 9: 685-693.
3. Nagy JA, Senger DR (2006) VEGF-A, cytoskeletal dynamics, and the pathological vascular phenotype. Exp Cell Res 312: 538-548.
4. Ozawa CR, Banfi A, Glazer NL, Thurston G, Springer ML, et al. (2004) Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis. J Clin Invest 113: 516-527.
5. Chae JK, Kim I, Lim ST, Chung MJ, Kim WH, et al. (2000) Coadministration of angiopoietin-1 and vascular endothelial growth factor enhances collateral vascularization. Arterioscler Thromb Vasc Biol 20: 2573-2578.
6. Goll DE, Thompson VF, Li H, Wei W, Cong J (2003) The calpain system. Physiol Rev 83: 731-801.
7. Potter DA, Tirnauer JS, Janssen R, Croall DE, Hughes CN, et al. (1998) Calpain regulates actin remodeling during cell spreading. J Cell Biol 141: 647-662.
8. Kulkarni S, Saido TC, Suzuki K, Fox JE (1999) Calpain mediates integrininduced signaling at a point upstream of Rho family members. J Biol Chem 274: 21265-21275.
9. Bhatt A, Kaverina I, Otey C, Huttenlocher A (2002) Regulation of focal complex composition and disassembly by the calcium-dependent protease calpain. J Cell Sci 115: 3415-3425.
10. Glading A, Lauffenburger DA, Wells A (2002) Cutting to the chase: calpain proteases in cell motility. Trends Cell Biol 12: 46-54.
11. Dourdin N, Bhatt AK, Dutt P, Greer PA, Arthur JS, et al. (2001) Reduced cell migration and disruption of the actin cytoskeleton in calpain-deficient embryonic fibroblasts. J Biol Chem 276: 48382-48388.
12. Franco SJ, Huttenlocher A (2005) Regulating cell migration: calpains make the cut. J Cell Sci 118: 3829-3838.
13. Su Y, Cui Z, Li Z, Block ER (2006) Calpain-2 regulation of VEGF-mediated angiogenesis. Faseb J 20: 1443-1451.
14. Bodnar RJ, Yates CC, Wells A (2006) IP-10 blocks vascular endothelial growth factor-induced endothelial cell motility and tube formation via inhibition of calpain. Circ Res 98: 617-625.
15. Hoang MV, Whelan MC, Senger DR (2004) Rho activity critically and selectively regulates endothelial cell organization during angiogenesis. Proc Natl Acad Sci USA 101: 1874-1879.
16. Hoang MV, Senger DR (2005) In vivo and in vitro models of mammalian angiogenesis. Methods Mol Biol 294: 269-285.
17. Zeng H, Qin L, Zhao D, Tan X, Manseau EJ, et al. (2006) Orphan nuclear receptor TR3/Nur77 regulates VEGF-A-induced angiogenesis through its transcriptional activity. J Exp Med 203: 719-729.
18. Drake CJ, Little CD (1999) VEGF and vascular fusion: implications for normal and pathological vessels. J Histochem Cytochem 47: 1351-1356.
19. Davis GE, Camarillo CW (1996) An alpha 2 beta 1 integrin-dependent pinocytic mechanism involving intracellular vacuole formation and coalescence regulates capillary lumen and tube formation in three-dimensional collagen matrix. Exp Cell Res 224: 39-51.
20. Whelan MC, Senger DR (2003) Collagen I initiates endothelial cell morphogenesis by inducing actin polymerization through suppression of cyclic AMP and protein kinase A. J Biol Chem 278: 327-334.
21. Vernon RB, Sage EH (1995) Between molecules and morphology. Extracellular matrix and creation of vascular form. Am J Pathol 147: 873-883.
22. Drake CJ, Fleming PA (2000) Vasculogenesis in the day 6.5 to 9.5 mouse embryo. Blood 95: 1671-1679.
23. Maki M, Bagci H, Hamaguchi K, Ueda M, Murachi T, et al. (1989) Inhibition of calpain by a synthetic oligopeptide corresponding to an exon of the human calpastatin gene. J Biol Chem 264: 18866-18869.
24. Tompa P, Buzder-Lantos P, Tantos A, Farkas A, Szilagyi A, et al. (2004) On the sequential determinants of calpain cleavage. J Biol Chem 279: 20775-20785.
25. Takemura R, Okabe S, Umeyama T, Kanai Y, Cowan NJ, et al. (1992) Increased microtubule stability and alpha tubulin acetylation in cells transfected with microtubule-associated proteins MAP1B, MAP2 or tau. J Cell Sci 103(Pt 4): 953-964.
26. Esmaeli-Azad B, McCarty JH, Feinstein SC (1994) Sense and antisense transfection analysis of tau function: tau influences net microtubule assembly, neurite outgrowth and neuritic stability. J Cell Sci 107(Pt 4). pp 869-879.
27. Kulkarni S, Goll DE, Fox JE (2002) Calpain cleaves RhoA generating a dominant-negative form that inhibits integrin-induced actin filament assembly and cell spreading. J Biol Chem 277: 24435-24441.
28. Rami A, Krieglstein J (1993) Protective effects of calpain inhibitors against neuronal damage caused by cytotoxic hypoxia in vitro and ischemia in vivo. Brain Res 609: 67-70.
29. Ruetten H, Thiemermann C (1997) Effect of calpain inhibitor I, an inhibitor of the proteolysis of I kappa B, on the circulatory failure and multiple organ dysfunction caused by endotoxin in the rat. Br J Pharmacol 121: 695-704.
30. Cuzzocrea S, McDonald MC, Mazzon E, Siriwardena D, Serraino I, et al. (2000) Calpain inhibitor I reduces the development of acute and chronic inflammation. Am J Pathol 157: 2065-2079.
31. McDonald MC, Mota-Filipe H, Paul A, Cuzzocrea S, Abdelrahman M, et al. (2001) Calpain inhibitor I reduces the activation of nuclear factor-kappaB and organ injury/dysfunction in hemorrhagic shock. Faseb J 15: 171-186.
32. Fujitani K, Kambayashi J, Sakon M, Ohmi SI, Kawashima S, et al. (1997) Identification of mu-, m-calpains and calpastatin and capture of mu-calpain activation in endothelial cells. J Cell Biochem 66: 197-209.
33. Glading A, Bodnar RJ, Reynolds IJ, Shiraha H, Satish L, et al. (2004) Epidermal growth factor activates m-calpain (calpain II), at least in part, by extracellular signal-regulated kinase-mediated phosphorylation. Mol Cell Biol 24: 2499-2512.
34. Brock TA, Dvorak HF, Senger DR (1991) Tumor-secreted vascular permeability factor increases cytosolic Ca2+ and von Willebrand factor release in human endothelial cells. Am J Pathol 138: 213-221.
35. Pocock TM, Foster RR, Bates DO (2004) Evidence of a role for TRPC channels in VEGF-mediated increased vascular permeability in vivo. Am J Physiol Heart Circ Physiol 286: H1015-1026.
36. Kroll J, Waltenberger J (1997) The vascular endothelial growth factor receptor KDR activates multiple signal transduction pathways in porcine aortic endothelial cells. J Biol Chem 272: 32521-32527.
37. Robinson GS, Pierce EA, Rook SL, Foley E, Webb R, et al. (1996) Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy. Proc Natl Acad Sci USA 93: 4851-4856.
38. Huttenlocher A, Palecek SP, Lu Q, Zhang W, Mellgren RL, et al. (1997) Regulation of cell migration by the calcium-dependent protease calpain. J Biol Chem 272: 32719-32722.
39. Gonscherowski V, Becker BF, Moroder L, Motrescu E, Gil-Parrado S, et al. (2006) Calpains: a physiological regulator of the endothelial barrier? Am J Physiol Heart Circ Physiol 290: H2035-2042.
40. Voisine P, Bianchi C, Ruel M, Malik T, Rosinberg A, et al. (2004) Inhibition of the cardiac angiogenic response to exogenous vascular endothelial growth factor. Surgery 136: 407-415.
41. Boodhwani M, Sellke FW (2009) Therapeutic angiogenesis in diabetes and hypercholesterolemia: influence of oxidative stress. Antioxid Redox Signal 11: 1945-1959.
42. Bayless KJ, Davis GE (2004) Microtubule depolymerization rapidly collapses capillary tube networks in vitro and angiogenic vessels in vivo through the small GTPase Rho. J Biol Chem 279: 11686-11695.
43. Wilson MT, Kisaalita WS, Keith CH (2000) Glutamate-induced changes in the pattern of hippocampal dendrite outgrowth: a role for calcium-dependent pathways and the microtubule cytoskeleton. J Neurobiol 43: 159-172.
44. Robles E, Huttenlocher A, Gomez TM (2003) Filopodial calcium transients regulate growth cone motility and guidance through local activation of calpain. Neuron 38: 597-609.
45. Lovestone S, Hartley CL, Pearce J, Anderton BH (1996) Phosphorylation of tau by glycogen synthase kinase-3 beta in intact mammalian cells: the effects on the organization and stability of microtubules. Neuroscience 73: 1145-1157.
46. Xie H, Litersky JM, Hartigan JA, Jope RS, Johnson GV (1998) The interrelationship between selective tau phosphorylation and microtubule association. Brain Res 798: 173-183.
47. Horwitz SB (1992) Mechanism of action of taxol. Trends Pharmacol Sci 13: 134-136.
48. Shannon KB, Canman JC, Ben Moree C, Tirnauer JS, Salmon ED (2005) Taxol-stabilized microtubules can position the cytokinetic furrow in mammalian cells. Mol Biol Cell 16: 4423-4436.
49. Xiao H, Verdier-Pinard P, Fernandez-Fuentes N, Burd B, Angeletti R, et al. (2006) Insights into the mechanism of microtubule stabilization by Taxol. Proc Natl Acad Sci USA 103: 10166-10173.
50. Hotchkiss KA, Ashton AW, Mahmood R, Russell RG, Sparano JA, et al. (2002) Inhibition of endothelial cell function in vitro and angiogenesis in vivo by docetaxel (Taxotere): association with impaired repositioning of the microtubule organizing center. Mol Cancer Ther 1: 1191-1200.
51. Wang J, Lou P, Lesniewski R, Henkin J (2003) Paclitaxel at ultra low concentrations inhibits angiogenesis without affecting cellular microtubule assembly. Anticancer Drugs 14: 13-19.
52. Grant DS, Williams TL, Zahaczewsky M, Dicker AP (2003) Comparison of antiangiogenic activities using paclitaxel (taxol) and docetaxel (taxotere). Int J Cancer 104: 121-129.
53. Tapon N, Hall A (1997) Rho, Rac and Cdc42 GTPases regulate the organization of the actin cytoskeleton. Curr Opin Cell Biol 9: 86-92.
54. Kaibuchi K, Kuroda S, Amano M (1999) Regulation of the cytoskeleton and cell adhesion by the Rho family GTPases in mammalian cells. Annu Rev Biochem 68: 459-486.
55. De Smet F, Segura I, De Bock K, Hohensinner PJ, Carmeliet P (2009) Mechanisms of vessel branching: filopodia on endothelial tip cells lead the way. Arterioscler Thromb Vasc Biol 29: 639-649.
56. Davis GE, Camarillo CW (1995) Regulation of endothelial cell morphogenesis by integrins, mechanical forces, and matrix guidance pathways. Exp Cell Res 216: 113-123.
57. Senger DR, Claffey KP, Benes JE, Perruzzi CA, Sergiou AP, et al. (1997) Angiogenesis promoted by vascular endothelial growth factor: regulation through alpha1beta1 and alpha2beta1 integrins. Proc Natl Acad Sci USA 94: 13612-13617.
58. Nagy JA, Morgan ES, Herzberg KT, Manseau EJ, Dvorak AM, et al. (1995) Pathogenesis of ascites tumor growth: angiogenesis, vascular remodeling, and stroma formation in the peritoneal lining. Cancer Res 55: 376-385.
59. Richard L, Velasco P, Detmar M (1998) A simple immunomagnetic protocol for the selective isolation and long-term culture of human dermal microvascular endothelial cells. Exp Cell Res 240: 1-6.
60. Le Doux JM, Landazuri N, Yarmush ML, Morgan JR (2001) Complexation of retrovirus with cationic and anionic polymers increases the efficiency of gene transfer. Hum Gene Ther 12: 1611-1621.
61. Smith LE, Shen W, Perruzzi C, Soker S, Kinose F, et al. (1999) Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor. Nat Med 5: 1390-1395.
62. Senger DR, Perruzzi CA, Streit M, Koteliansky VE, de Fougerolles AR, et al. (2002) The alpha(1)beta(1) and alpha(2)beta(1) integrins provide critical support for vascular endothelial growth factor signaling, endothelial cell migration, and tumor angiogenesis. Am J Pathol 160: 195-204.
63. Ren XD, Kiosses WB, Schwartz MA (1999) Regulation of the small GTPbinding protein Rho by cell adhesion and the cytoskeleton. Embo J 18: 578-585.
64. Senger DR, Connolly DT, Van de Water L, Feder J, Dvorak HF (1990) Purification and NH2-terminal amino acid sequence of guinea pig tumorsecreted vascular permeability factor. Cancer Res 50: 1774-1778.
65. Sioussat TM, Dvorak HF, Brock TA, Senger DR (1993) Inhibition of vascular permeability factor (vascular endothelial growth factor) with antipeptide antibodies. Arch Biochem Biophys 301: 15-20.
66. Rosser BG, Gores GJ (2000) Cellular in vivo assay of calpain activity using a fluorescent substrate. Application to study of anoxic liver injury. Methods Mol Biol 144: 245-259.